Is it too soon for mesenchymal stem cell trials in people with ALS?
- PMID: 18819027
- DOI: 10.1080/17482960802425559
Is it too soon for mesenchymal stem cell trials in people with ALS?
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting primarily the motor neurons. Stem cell therapy is under development as a possible treatment approach. A pilot study of intraspinal injections of mesenchymal stem cells (MSC) was conducted in 9 participants. We review this paper, the rationale, preclinical data and study design.
Comment in
-
Mesenchymal stem cells for ALS patients.Amyotroph Lateral Scler. 2009 Apr;10(2):123-4. doi: 10.1080/17482960802572707. Amyotroph Lateral Scler. 2009. PMID: 19085190 No abstract available.
Comment on
-
Stem cell treatment in Amyotrophic Lateral Sclerosis.J Neurol Sci. 2008 Feb 15;265(1-2):78-83. doi: 10.1016/j.jns.2007.05.016. Epub 2007 Jun 19. J Neurol Sci. 2008. PMID: 17582439 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources